The bioresorbable magnesium scaffold (Magmaris)—State of the art: From basic concept to clinical application

P Rola, S Włodarczak, A Doroszko… - Catheterization and …, 2022 - Wiley Online Library
Since its introduction to clinical practice, coronary artery stent implantation has become a
crucial part of the therapy of coronary artery disease (CAD). Despite the undeniable …

Development and Future Trends of Protective Strategies for Magnesium Alloy Vascular Stents

D Liu, K Yang, S Chen - Materials, 2023 - mdpi.com
Magnesium alloy stents have been extensively studied in the field of biodegradable metal
stents due to their exceptional biocompatibility, biodegradability and excellent …

Mid-term safety and efficacy of magnesium bioresorbable vascular scaffolds–magmaris in diabetic population. 2-Years outcome in acute coronary syndrome cohort

A Włodarczak, P Rola, M Barycki… - … & Vascular Disease …, 2023 - journals.sagepub.com
Background Diabetes type 2 is one of the strongest risk factors affecting coronary artery
disease (CAD) and is also a marker of poor short and long-term prognosis in subjects with …

Magnesium bioresorbable scaffold (Magmaris) versus polymer biodegradable ultrathin drug-eluting stent (Ultimaster) in acute coronary syndrome. Mid-term outcomes …

A Włodarczak, P Rola, S Włodarczak… - … Cardiology/Postępy w …, 2024 - termedia.pl
Aim: We designed this study to evaluate the mid-term safety and efficiency of the Magmaris
BRS in comparison to the leading new-generation ultrathin DES Ultimaster in the ACS …

Long-term outcomes following bioresorbable vascular scaffolds

K Miyashita, K Ninomiya, A Tobe… - Expert Review of …, 2024 - Taylor & Francis
Introduction The higher scaffold thrombosis rates observed with the first-generation
bioresorbable scaffolds (BRSs) compared to conventional drug-eluting stents were likely …

A word of caution: early failure of Magmaris® bioresorbable stent after pulmonary artery stenting

RN Haddad, A Adel Hassan, M Al Soufi… - Catheterization and …, 2023 - Wiley Online Library
Bioresorbable scaffolds (BRS) have been advocated as the fourth revolution in
interventional cardiology medical devices with promising technology to improve the …

The Short‐Term and One‐Year Clinical Outcomes in Patients with Optical Coherence Tomography‐Guided Magmaris Implantation: A Real‐World Clinical Practice

MJ Chuang, WC Huang, YY Chen… - Journal of Interventional …, 2024 - Wiley Online Library
Aims. We aimed to evaluate the acute performance and short‐and long‐term outcomes of
optical coherence tomography (OCT)‐guided Magmaris deployment. Methods. This was a …

Two-Year Outcomes for Patients with Non-ST-Elevation Acute Coronary Syndrome Treated with Magmaris and Absorb Bioresorbable Scaffolds in Large-Vessel …

A Włodarczak, P Rola, S Włodarczak… - Journal of Personalized …, 2024 - mdpi.com
Background: The acute coronary syndrome (ACS) continues to be a fundamental indication
for revascularization by percutaneous coronary intervention (PCI). Drug-eluting stent (DES) …

医用镁合金元素选择的研究现状

刘安宏, 蔡萌萌, 韩笑, 王战会 - 中国组织工程研究, 2024 - cjter.com
医用镁合金元素选择的研究现状 中国组织工程研究 首页 关于本刊 编委会 在线投稿 期刊公告
出版道德 OA政策 作者学院 在线问答 联系我们 English 中国组织工程研究 ›› 2024, Vol. 28 ›› …

Research status on element selection of medical magnesium alloy

A Liu, M Cai, X Han, Z Wang - Chinese Journal of Tissue Engineering …, 2024 - cjter.com
BACKGROUND: Due to natural degradation, excellent biocompatibility and good
mechanical properties, magnesium alloy has become a very valuable implant material in the …